|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004048,
umls-concept:C0004096,
umls-concept:C0008972,
umls-concept:C0009491,
umls-concept:C0015458,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0040866,
umls-concept:C0298501,
umls-concept:C0599677,
umls-concept:C0699690,
umls-concept:C1112870,
umls-concept:C1257890,
umls-concept:C1579762
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-11-10
|
|
pubmed:abstractText |
Triamcinolone acetonide (TAA) inhalation aerosol (Azmacort Inhalation Aerosol), a well-established corticosteroid treatment for bronchial asthma, utilizes the chlorofluorocarbon (CFC) propellant P-12, which will be phased out because of environmental concerns. Two TAA aerosol formulations have been developed using a non-chlorofluorocarbon propellant, HFA-134a (Azmacort HFA Inhalation Aerosol delivering TAA 75 microg/puff or 225 microg/puff).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1081-1206
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
327-33
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10541425-Administration, Inhalation,
pubmed-meshheading:10541425-Adolescent,
pubmed-meshheading:10541425-Adult,
pubmed-meshheading:10541425-Aerosol Propellants,
pubmed-meshheading:10541425-Aerosols,
pubmed-meshheading:10541425-Aged,
pubmed-meshheading:10541425-Albuterol,
pubmed-meshheading:10541425-Anti-Asthmatic Agents,
pubmed-meshheading:10541425-Asthma,
pubmed-meshheading:10541425-Chlorofluorocarbons,
pubmed-meshheading:10541425-Double-Blind Method,
pubmed-meshheading:10541425-Drug Therapy, Combination,
pubmed-meshheading:10541425-Forced Expiratory Volume,
pubmed-meshheading:10541425-Glucocorticoids,
pubmed-meshheading:10541425-Humans,
pubmed-meshheading:10541425-Hydrocarbons, Fluorinated,
pubmed-meshheading:10541425-Male,
pubmed-meshheading:10541425-Middle Aged,
pubmed-meshheading:10541425-Safety,
pubmed-meshheading:10541425-Treatment Outcome,
pubmed-meshheading:10541425-Triamcinolone Acetonide
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
|
|
pubmed:affiliation |
Allergy and Asthma Research Group, Eugene, Oregon, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
